Cat.#: ACPP-1747
| Despition | TSG Human Recombinant |
| SIZE | 10 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1235 | C1orf187 Blocking Peptide (AC1235) | 250 µg | inquiry |
| ACPP-1656 | Human MAPT Protein (AC1656) | 2 µg | inquiry |
| ACPP-1323 | FYN Blocking Peptide (AC1323) | 250 µg | inquiry |
| ACPP-1555 | Human TGFBI Protein, 182 a.a. (AC1555) | 10 µg | inquiry |
| ACPP-1291 | FGFR1 Blocking Peptide (AC1291) | 250 µg | inquiry |
| ACPP-1097 | Synthetic Nanodisc Human ENTPD2 Protein (AC1097) | 10 µg | inquiry |
| ACPP-1251 | EAAT2 Blocking Peptide (AC1251) | 250 µg | inquiry |
| ACPP-1818 | Mouse FGF 9 Protein (AC1818) | 2 µg | inquiry |
| ACPP-1502 | Human DAG1 Protein (AC1502) | 2 µg | inquiry |
| ACPP-1126 | Recombinant Human Peripherin Protein (AC1126) | 25 µl | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.